FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and medicine, namely to manufacturing drug preparations for treating allergic diseases, such as allergic rhinitis and urticaria. According to the first version, the pharmaceutical composition contains an active substance that is desloratadine, and additives, including citric acid, calcium hydrogen phosphate dihydrate, microcrystalline cellulose, starch, lactose, magnesium stearate, and talc. According to the second version, the pharmaceutical composition contains an active substance that is desloratadine, and additives, including Pearlitol 100SD-Mannitol, calcium hydrogen phosphate dihydrate, microcrystalline cellulose, starch, magnesium stearate, and talc. According to the third version, the pharmaceutical composition contains an active substance that is desloratadine, and additives, including sodium carboxymethyl starch, microcrystalline cellulose, colloidal silicone dioxide, and sodium sodium stearyl fumarate. According to the fourth version, the pharmaceutical composition contains an active substance that is desloratadine, and additives, including sodium carboxymethyl starch, microcrystalline cellulose, Pearlitol 100SD-Mannitol, magnesium stearate, and talc. The pharmaceutical composition is presented in the form of a film-coated tablet.
EFFECT: pharmaceutical composition according to the invention is storage-stable and releases the active substance quickly in the gastrointestinal tract.
10 cl, 9 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
WATER-DISPERSIBLE DESLORATADINE PILL AND METHOD FOR ITS MANUFACTURE | 2015 |
|
RU2631619C2 |
ANTIVIRAL AND IMMUNOSTIMULATING DRUG | 2015 |
|
RU2593570C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM SALT (VERSIONS) | 2015 |
|
RU2606592C1 |
DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
ANTACID AND METHODS FOR PRODUCING IT (VERSIONS) | 2013 |
|
RU2567800C2 |
COMBINED ANTIHYPERTENSIVE DRUG AND METHOD FOR PREPARING IT | 2011 |
|
RU2483728C1 |
PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
PHARMACEUTICAL COMPOSITION OF IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD FOR PREPARING IT AND METHOD(S) OF TREATING | 2012 |
|
RU2517216C2 |
Authors
Dates
2014-12-27—Published
2013-06-18—Filed